Company / Interest Expense
PROKIDNEY CORP. Interest Expense History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$9.0K
FY2024
5-year range
$0 / $215.0K
FY2020-FY2024
Trend
-25.0%
vs FY2023
Sector context
#38 of 44
Health Care
What the data says
PROKIDNEY CORP.'s interest expense of $9,000 is lower than 86% of companies in the Health Care sector (FY2024). Improved from $215,000 to $9,000 over the past 2 years.
Based on SEC 10-K filings.
$9,000 in FY2024.
Improved from $215,000 to $9,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 44This company $9.0K Sector average $291.0M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, interest expense decreased 25.0% year-over-year.
- Ranks #38 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2022.
- Lowest interest expense in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $9.0K | -25.0% |
| FY2023 | $12.0K | -94.4% |
| FY2022 | $215.0K | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026